Hargreaves Lansdown plc (LON:HL) today confirmed that Alison Platt, Non-Executive Chair of HL, has been appointed to the Takeover Panel to be a member of the Panel designated to sit on the Hearings Committee with effect from May 1, 2025.
Ms Platt has extensive leadership experience across both private and listed companies in the healthcare, financial services, retail and property, and regulated sectors. She was CEO of Countrywide from 2014 – 2018 and prior to that she held several senior roles at BUPA, including as Managing Director of its International Development Markets business.
She was previously a Non-executive director of the Foreign and Commonwealth Office, Chair of Dechra Pharmaceuticals plc, a member of Hampton-Alexander review steering group advising on diversity and inclusion and Chair of Opportunity Now.